| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 728.9 | 698.9 |
| Profit before tax | 77.7 | 55.7 |
| Net income | 62.3 | 46.7 |
| EPS (diluted, $ a share) | $0.56 | $0.40 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +33.5% |
|---|---|
| Revenue, year on year | +4.3% |
| Operating margin | 13.1% |
10-Q filed with the SEC, NYSE: RVTY. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Revvity, Inc.: key numbers
- Share price
- $148.85Close, Nov 16
- Market cap
- $16.6B
- Shares outstanding
- 111.64MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Laboratory Analytical InstrumentsSIC 3826
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Revvity, Inc.
All →Revvity Investor Presentation
Revvity is hosting its 2026 Investor Day to showcase its 'Powering Scientific Intelligence' strategy, focusing on AI-enabled discovery workflows and its Life Sciences and Diagnostics portfolio. Management will outline strategic priorities, operational initiatives, and the company's long-range financial outlook to investors.
Revvity Financial Results
Revvity reported third quarter 2026 financial results with revenue of $729 million and adjusted EPS of $1.38, exceeding expectations. The company raised its full-year guidance and provided pro forma financials reflecting the pending $200 million divestiture of its China Immunodiagnostics business. Management noted improving end-market conditions and strong execution across its Life Sciences and Diagnostics segments.
“Our exceptional third quarter performance demonstrates the momentum building across Revvity, as broad-based growth and strong execution drove results meaningfully ahead of our expectations. With end market conditions continuing to improve, a strong pipeline of innovation, and the benefits of our transformation increasingly evident in our results, Revvity is extremely well positioned to capitalize on the opportunities ahead.”
Prahlad Singh, president and chief executive officer of Revvity
Revvity VP and CAO Anita Gonzales Sells $13.1K of Stock
Anita Gonzales, VP and CAO, sold 84 shares of Revvity, Inc. at $155.48 a share, worth $13.1K in total on Oct 1, 2026. Shares held after the trade: 7,117 (-1.2%).
- Value
- $13.1K
- Shares
- 84
- Price
- $155.48
- Role
- VP and CAO
- Holding change
- -1.2%
- Trade date
- Oct 1, 2026
Revvity Please See Remarks Tajinder S. Vohra Sells $1.03M of Stock
Tajinder S. Vohra, Please See Remarks, sold 7,330 shares of Revvity, Inc. at $140.88 a share, worth $1.03M in total on Sep 16, 2026. Shares held after the trade: 6,635 (-52.5%).
- Value
- $1.03M
- Shares
- 7,330
- Price
- $140.88
- Role
- Please See Remarks
- Holding change
- -52.5%
- Trade date
- Sep 16, 2026